MYC-driven double hit diffuse large B-cell lymphoma (DHL) is a molecularly defined subset with an aggressive clinical course that requires novel targeted combinations of agents to provide a high impact on survival. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.